Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector
Launched by UNIVERSITY OF CAMPINAS, BRAZIL · Jul 11, 2011
Trial Information
Current as of August 28, 2025
Completed
Keywords
ClinConnect Summary
100 women were either allocated to received Implanon contraceptive implant, the LNG-IUS or TCu380A copper-IUD. The women were allocated according to their preference on each of the contraceptive methods.
half of the women will receive the common counseling at the clinic and the other 50% will receive intense counselling about menstrual changes induced by these three contraceptive methods. The continuation rate up to one year will be evaluated through life-table analysis
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women 18 to 40 years
- • New users of Implanon, IUDs and the LNG-IUS TCu380A
- Exclusion Criteria:
- • Contraindications to contraceptive methods
About University Of Campinas, Brazil
The University of Campinas (Universidade Estadual de Campinas, UNICAMP) is a prestigious research institution located in Brazil, renowned for its commitment to advancing knowledge and innovation in the medical and scientific fields. With a strong emphasis on interdisciplinary collaboration, UNICAMP conducts cutting-edge clinical trials aimed at improving healthcare outcomes and developing novel therapeutic approaches. The university leverages its extensive resources, including state-of-the-art laboratories and a team of highly qualified researchers and clinicians, to contribute significantly to the global body of medical research while fostering education and training in clinical and translational sciences.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Campinas, Sp, Brazil
Patients applied
Trial Officials
Luis Bahamondes, MD
Principal Investigator
University of Campinas, Brazil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials